Contextual reprogramming of CAR-T cells for treatment of HER2+ cancers
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Translational Medicine"
DOI: 10.1186/s12967-021-03132-6
Abstract: Background Adoptive transfer of chimeric antigen receptor (CAR)-engineered T cells combined with checkpoint inhibition may prevent T cell exhaustion and improve clinical outcomes. However, the approach is limited by cumulative costs and toxicities. Methods To… read more here.
Keywords: cells treatment; contextual reprogramming; reprogramming car; car cells ... See more keywords